跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LABETALOL HYDROCHLORIDE INJECTION
Authorized
STANDARD
LABETALOL HYDROCHLORIDE INJECTION
omega laboratories limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bc4378529ebe55f2
Company
omega laboratories limited
Type
Standard
Approval Details
Approval Id
bc4378529ebe55f2
Drug Approval Canada Name
LABETALOL HYDROCHLORIDE INJECTION
Product Name
LABETALOL HYDROCHLORIDE INJECTION
Status
Marketed
Status Date
2018-06-02
Original Market Date
2018-06-02
Din
02457040
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AG01 LABETALOL
Atc Name
c 07 ag 01
Aig Number
0116170002
Company Name
omega laboratories limited
Company Address
11177 Hamon, Montreal, Quebec, Canada, H3M 3E4
Active Ingredients
LABETALOL HYDROCHLORIDE
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bc4378529ebe55f2
Type
Standard
Back to Health Canada Approvals
LABETALOL HYDROCHLORIDE INJECTION - Health Canada Drug Approval Details